US Medicare Oncology Demo Should Test Value-Based Drug Pricing – Providers

 
• By Cathy Kelly
  
Doctor
AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Merck & Co. and Sanofi would consider participating in a revised pilot program, COA says. • Source: Shutterstock

More from Market Access

More from Pink Sheet